Advances and challenges in phenylketonuria

Journal of Inherited Metabolic Disease

Volumn 33, Issue 6, 2010, Pages 645-648

  Harding, Cary O ^a   Blau, Nenad ^b,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLALANINE 4 MONOOXYGENASE; SAPROPTERIN; TETRAHYDROBIOPTERIN; 5,6,7,8-TETRAHYDROBIOPTERIN; BIOPTERIN; DRUG DERIVATIVE;

ADENO ASSOCIATED VIRUS; CATALYSIS; CONGENITAL HEART DISEASE; DEGENERATIVE DISEASE; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; EDITORIAL; ENZYME ACTIVITY; ENZYME REPLACEMENT; ENZYME SYNTHESIS; GAIT DISORDER; GENE MUTATION; GENE THERAPY; HUMAN; HYDROXYLATION; HYPERPHENYLALANINEMIA; LIVER TRANSPLANTATION; LOADING DRUG DOSE; MENTAL DEFICIENCY; MICROCEPHALY; NEWBORN SCREENING; NONHUMAN; PHENOTYPE; PHENYLKETONURIA; PROTEIN EXPRESSION; REPEATED DRUG DOSE; SEIZURE; ANIMAL; GENETICS; METHODOLOGY; MOUSE; NEWBORN; STANDARD; THERAPY; TRANSGENIC MOUSE;

ANIMALS; BIOPTERIN; ENZYME REPLACEMENT THERAPY; GENE THERAPY; HUMANS; INFANT, NEWBORN; MICE; MICE, TRANSGENIC; NEONATAL SCREENING; PHENYLALANINE HYDROXYLASE; PHENYLKETONURIAS; THERAPEUTICS;

EID: 79952552483     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-010-9247-7     Document Type: Editorial

References (29)

1. Anon (2001) National institutes of health consensus development conference statement: phenylketonuria: screening and management, October 16-18, 2000. Pediatrics 108(4): 972-982
2. Azen C et al (1996) Summary of findings from the United States collaborative study of children treated for phenylketonuria. Eur J Pediatr 155 Suppl 1:S29-S32
3. Blau N (2010) Sapropterin dihydrochloride for phenylketonuria and tetrahydrobiopterin deficiency. Expert Rev Endocrinol Metab 5 (4):483-494
4. Blau N et al (2009) Optimizing the use of sapropterin (BH4) in the management of phenylketonuria. Mol Genet Metab 96:158-163
5. Blau N et al (2004) The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. Mol Genet Metab 82:101-111 (Pubitemid 38692547)
6. Blau N et al. (2001) Disorders of tetrahydrobiopterin and related biogenic amines. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. New York, McGraw-Hill, pp 1725-1776
7. Blau N et al (2010) Phenylketonuria. Lancet 376:1417-1427
8. Ding Z et al (2006) Administration-route and gender-independent long-term therapeutic correction of phenylketonuria (PKU) in a mouse model by recombinant adeno-associated virus 8 pseudotyped vector-mediated gene transfer. Gene Ther 13(7):587-593
9. Ding Z et al (2008) Correction of murine PKU following AAV-mediated intramuscular expression of a complete phenylalanine hydroxylating system. Mol Ther 16(4):673-681 (Pubitemid 351426168)
10. Fang B et al (1994) Gene therapy for phenylketonuria: phenotypic correction in a genetically deficient mouse model by adenovirus-mediated hepatic gene therapy. Gene Ther 1:247-254
11. Fiege B et al (2007) Assessment of tetrahydrobiopterin (BH4)-responsiveness in phenylketonuria. J Pediatr 150:627-630
12. Gersting SW et al (2008) Loss of function in phenylketonuria is caused by impaired molecular motions and conformational instability. Am J Hum Genet 83(1):5-17
13. Hamman K et al (2005) Low therapeutic threshold for hepatocyte replacement in murine phenylketonuria. Mol Ther 12(2):337-344 (Pubitemid 41025105)
14. Harding C (2008) Progress toward cell-directed therapy for phenylketonuria. Clin Genet 74(2):97-104
15. Harding CO (2010) New era in treatment for phenylketonuria: pharmacologic therapy with sapropterin dihydrochloride. Biologics 4:231-236
16. Harding CO et al. (2010) Therapeutic liver repopulation for phenylketonuria. J Inherit Metab Dis (in press)
17. Harding CO et al (2006) Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2/8 vector-mediated gene therapy in murine phenylketonuria. Gene Ther 13(5):457-462
18. Kure S et al (1999) Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. J Pediatr 135(3):375-378 (Pubitemid 30180515)
19. Levy HL et al (2003) Pregnancy experiences in the woman with mild hyperphenylalaninemia. Pediatrics 112(6 Pt 2):1548-1552 (Pubitemid 37521695)
20. McDonald JD et al (2002) The phenylketonuria mouse model: a meeting review. Mol Genet Metab 76(4):256-261
21. McDonald JD et al (1997) Characterization of mutations at the mouse phenylalanine hydroxylase locus. Genomics 39(3):402-405 (Pubitemid 27078708)
22. Pey AL et al (2004) Mechanisms underlying responsiveness to tetrahydrobiopterin in mild phenylketonuria mutations. Hum Mutat 24(5):388-399 (Pubitemid 39473664)
23. Pey AL et al (2007) Predicted effects of missense mutations on nativestate stability account for phenotypic outcome in phenylketonuria, a paradigm of misfolding diseases. Am J Hum Genet 81 (5):1006-1024 (Pubitemid 47580253)
24. Rebuffat A et al (2010) Comparison of adeno-associated virus pseudotype 1, 2, and 8 vectors administered by intramuscular injection in the treatment of murine phenylketonuria. Hum Gene Ther 21(4):463-477
25. Sarkissian CN et al (2005) Phenylalanine ammonia lyase, enzyme substitution therapy for phenylketonuria, where are we now? Mol Genet Metab 86 Suppl 1:S22-S26
26. Sarkissian CN et al (2008) Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria. Proc Natl Acad Sci USA 105 (52):20894-20899
27. Thöny B et al (2000) Tetrahydrobiopterin biosynthesis, regeneration, and functions. Biochem J 347:1-26
28. Thöny B et al (2006) Mutations in the BH4-metabolizing genes GTP cyclohydroalse I, 6-pyruvoyl-tetrahydropterin synthase, sepiapterin reductase, carbinolamine-4a-dehydratase, and dihydropteridine reductase genes. Human Mutat 27:870-878 (Pubitemid 44336936)
29. Woo SL et al (1983) Cloned human phenylalanine hydroxylase gene allows prenatal diagnosis and carrier detection of classical phenylketonuria. Nature 306(5939):151-155 (Pubitemid 14228337)